OMX30 1 581 0,1%  OMXH25 3 769 0,0%  OMXC20 904 -0,4%  Dow 20 702 0,7%  Nas 5 407 0,6%  EUR 9,5675 0,2%  USD 8,8655 0,4%  Olja 51,7 0,7%  Guld 1 253 -0,3% 

Baxter International Aktie

51,88USD 0,05USD 0,10%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Baxter International

2016 2017e 2018e 2019e 2020e
Utdelning 0,50 0,58 0,61 0,68 0,80
Direktavkastning (i %) 1,15 1,26 1,33 1,48 1,75
PE-tal 22,22 21,14 18,71 16,54 14,84
Resultat/aktie 1,96 2,17 2,45 2,77 3,08

Nyheter om Baxter International Inc.

ytterligare nyheter

Analyser om Baxter International Inc.

ytterligare analyser

Baxter International Peer Group

Baxter International 51,88
0,1%
Boston Scientific 24,70
0,5%
Cardinal Health 82,20
-0,1%
Fresenius Medical Care 78,49
0,6%
Fresenius 74,33
0,6%
Medtronic 80,72
-0,4%
STRATEC Biomedical 55,88
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Baxter International Inc.

till bolagsprofilen
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctor's offices and by patients at home under physician supervision. It operates through the following segments: Hospital Products and Renal. The Hospital Products segment intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation. The Renal segment provides products and services to treat end-stage renal disease, or irreversible kidney failure and acute kidney injuries. This segment offers a comprehensive portfolio to meet the needs of patients across the treatment continuum, including technologies and therapies for peritoneal dialysis, in-center hemodialysis, home HD, continuous renal replacement therapy and additional dialysis services. Baxter International was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Aktiekurs Baxter International Inc. i USDPUSH CHART

Kurs 51,88 USD 0,05 0,10 %
Kurstid 21:59:58
Datum 28.03.2017
Öppning 0,00
Gårdagen 51,88
Dagshögsta 0,00
Dagslägsta 0,00
52 v. högsta 52,33
52 v. lägsta 40,25
52 v. perf.
Volym (Antal) 0
Börsvärde (SEK) 245,65 Mrd
Börsen
Kurs för 51,88 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 459,94 SEK.

Till aktien Baxter International

Ticker
ISIN US0718131099
Index S&P 100, NYSE US 100, BX Swiss - USA, S&P 500

Baxter International Nyckeltal

Börsvärde i SEK 245,65 Mrd
Free float % 99,85
Antal aktier mio. 541,96
Cashflow/aktie i lokal valuta 2,28
Bokvärde/aktie i lokal valuta 17,02
60 dagar vola 24,79
PBV 2,56

Baxter International Historiska kurser

2017-03-28 51,88 140 736
2017-03-27 51,83 122 083
2017-03-24 52,03 139 096
2017-03-23 51,68 84 453
2017-03-22 51,79 210 656